Skip to content
The Policy VaultThe Policy Vault

FuroscixBlue Cross Blue Shield of Illinois

Requests for NM Fully Insured or NM HIM members for a rare disease

Initial criteria

  • The patient does NOT have any FDA labeled contraindications to the requested agent AND
  • The requested indication is a rare disease AND ONE of the following:
  • 1. The patient has another FDA labeled indication for the requested agent and route of administration OR
  • 2. The patient has another indication that is supported in compendia for the requested agent and route of administration OR
  • For Ohio members: ALL of the following:
  • A. The member resides in Ohio AND
  • B. The plan is Fully Insured or HIM Shop (SG) AND
  • C. The patient does NOT have any FDA labeled contraindications to the requested agent AND
  • D. ONE of the following:
  • 1. The patient has another FDA labeled indication for the requested agent and route of administration OR
  • 2. The patient has another indication that is supported in compendia for the requested agent and route of administration OR
  • 3. The prescriber has submitted TWO articles from major peer-reviewed professional medical journals (e.g., JAMA, NEJM, Lancet) supporting the proposed use(s) as generally safe and effective

Reauthorization criteria

  • Same as initial criteria

Approval duration

12 months